Fluidigm Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR1.25 |
Market Cap |
EUR281.93 M |
Shares Outstanding |
39.16 M |
Public Float |
15.49 M |
Fluidigm Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.59 |
Market Cap |
$799.94 M |
Shares Outstanding |
69.02 M |
Public Float |
68.37 M |
Address |
7000 Shoreline Court South San Francisco California 94080 United States |
Employees | - |
Website | http://www.fluidigm.com |
Updated | 07/08/2019 |
Fluidigm Corp. engages in the manufacture and marketing of innovative technologies and tools for life sciences research. It sells instruments and consumables, including integrated fluidic circuits; assays and reagents to academic institutions; clinical research laboratories, and biopharmaceutical; agricultural biotechnology; and companies and contract research organizations. The company was founded by Stephen R. |